Licensing
Having initiated collaborations around the world, REGENX is interested in continuing to build partnerships with biotechnology and pharmaceutical companies, research institutions, and foundations with complimentary expertise who are focused on furthering the research and therapeutic applications of novel adeno-associated virus technologies. We will also license our NAV™ Technology to qualified organizations. If you are interested in learning more about our partnership and license programs, please contact Vit Vasista at vvasista@regenxbio.com.
